Citation Impact

Citing Papers

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017
Immunotherapy in Inflammatory Bowel Disease
2012
Conventional Medical Management of Inflammatory Bowel Disease
2011
A view on drug resistance in cancer
2019 StandoutNature
Multidimensional prognostic indices for use in COPD patient care. A systematic review
2011
Microbial tryptophan catabolites in health and disease
2018 Standout
Long-term outcomes in pediatric-onset esophageal eosinophilia
2011
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics
2009
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
2014 Standout
Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut
2016
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
The Evolving Landscape of Brain Metastasis
2018
Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study
2008
Risk factors for neuropathic pain in diabetes mellitus
2016
Crohn's disease
2016 Standout
Type 2 diabetes
2017 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Neuropathic Pain in Diabetes, Prediabetes and Normal Glucose Tolerance: The MONICA/KORA Augsburg Surveys S2 and S3
2009
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
2014
Gut microbiota in human metabolic health and disease
2020 Standout
Irritable Bowel Syndrome
2015 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Comparison of Biologics and Oral Treatments for Plaque Psoriasis
2020
Risk of Incident Diabetes in Patients With Gout: A Cohort Study
2014
Diabetic polyneuropathy and pain, prevalence, and patient characteristics: a cross-sectional questionnaire study of 5,514 patients with recently diagnosed type 2 diabetes
2019
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Changes in Prescription Patterns of Acid‐Suppressant Medications by Belgian Pediatricians
2013
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
2016 Standout
Potential Overtreatment of Diabetes Mellitus in Older Adults With Tight Glycemic Control
2015
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Systematic review with meta‐analysis: effect of fibre supplementation on chronic idiopathic constipation in adults
2016

Works of E.Q. Wu being referenced

Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France
2007
Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy
2009
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy
2010
The economic burden of brain metastasis among lung cancer patients in the United States
2016
Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout
2013
Development of a COPD severity score
2006
PGI13 LOWER DISEASE ACTIVITY AND CLINICAL REMISSION ARE ASSOCIATED WITH REDUCED HOSPITALIZATION RISK IN CROHN'S DISEASE
2007
Continuous vs. Induction Only/Reinitiated Adalimumab Maintenance Therapy Yields Optimal Results for Moderate to Severe Crohnʼs Disease: Subanalysis of CHARM
2007
Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non‐insulin antidiabetes drugs
2012
Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation
2014
Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response
2014
Rankless by CCL
2026